AKT1 and B-cell chronic lymphocytic leukemia: Indeed in CLL signaling/transcriptional pathways, including MAPK, PI3K/AKT, Wnt/β-catenin, and NF-κB that promote cell survival have been reported to be deregulated [4,34,35].